Pocket Clinic


Development of a next generation injector

Pocket Clinic’s revolutionary system will enable people with diabetes to manage their blood glucose levels more precisely. 


More than 10% of people with diabetes need insulin every day. The current treatment is based on a very old technology and is not accessible to everyone. Over- or underdosing in this process is immensely dangerous.


Patients can control and adjust blood glucose levels through a smart injector that connects directly to the app on your smartphone and is cost effective.

Market size 

TAM – $35.5 billion globally

SAM – $18.48 billion in North America

SOM – $355 million is the 1% target

Business model 

Pocket Clinic offers personalized therapy using a combination of low-cost, high-tech devices with everyday devices such as smartphones and smartwatches. Microsystem technology (MEMS) is used, which allows the size and price to be significantly reduced. Microneedles are used to minimize pain and the injector is easy to use with a single button press.

The monthly subscription fee makes the system affordable for all income levels, even without insurance coverage. It will positively impact patients’ perception of insulin therapy and significantly improve their quality of life.

Monthly subscription for services – Purchase the system and pay for cartridges monthly.

3-Year Contract – Includes nutritional counseling and psychological services.

5-year contract – Includes nutritional counseling, psychology services, and a trainer.

Competitive advantages

The technology optimizes the treatment, is easy to use and completely painless. Pocket Clinic differs from its competitors in two key aspects that make it unique in this field: Interoperability and price. To this end, artificial intelligence algorithms deliver the exact amount of insulin tailored to the patient.

Share this Startup

TAM – Total available market

TAM is the total size of the market and corresponds to the long-term potential in perfect conditions without competitors.

SAM – Serviceable available market

SAM is the medium-term potential of a company that can realistically reach its target audience with its current product.

SOM – Realistically available market in the first phase

SOM describes the realistic potential assessment for the first phase of a company.